Press Releases

Fertility Services Market to Expand at a CAGR of 17.8 % from 2021 to 2030

The Fertility Services market is projected to reach US$ 25,720.9  Mn by 2030. And registering a CAGR of around 17.8% over the forecast period 2021 – 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38657

Growth Factors

 Fertility services are treatments or procedures used to cure genetic and fertility issues and help with conception. These services include Assisted Reproductive Technology (ART) methods and drugs that help single parents, infertile couples, and the Lesbian, Gay, Bisexual, and Transgender (LGBT) community in planning a family.

Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 42% of infertile couples, the male partner is responsible for infertility and among them, approximately 86%-92% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.

Fertility services have seen rapid expansion in recent years as a result of late marriages, newer contraceptive techniques, and an increasing number of women choosing their jobs above establishing a kid, resulting in an increase in the median age of first-time parenthood.

several significant market companies are interested in the development of innovative equipment for fertility treatments, which adds to the market’s growth. Additionally, increased health knowledge about reproduction concerns, the availability of fertility therapies, an increase in disposable income, and advantageous reimbursement regulations all contribute to market expansion.

Report Coverage

Report Scope Details
Market Size USD 25,720.9 million by 2030
Growth Rate CAGR of 17.8% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered End User, Service, Procedure
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned APOLLO HOSPITALS ENTERPRISE LTD., CARE FERTILITY GROUP LTD., CAROLINAS FERTILITY INSTITUTE, CITY FERTILITY, FERTILITY ASSOCIATES LIMITED, GENEA LIMITED, MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK), MONASH IVF GROUP LIMITED, PROGYNY INC., VIRTUS HEALTH

Key Players

  • APOLLO HOSPITALS ENTERPRISE LTD.
  • CARE FERTILITY GROUP LTD.
  • CAROLINAS FERTILITY INSTITUTE
  • CITY FERTILITY
  • FERTILITY ASSOCIATES LIMITED
  • GENEA LIMITED
  • MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
  • MONASH IVF GROUP LIMITED
  • PROGYNY INC.
  • VIRTUS HEALTH

Market Segmentation

  •  By End User
    • Fertility Clinics
    • Hospitals
    • Surgical Centers
    • Clinical Research Institutes
  • By Service
    • Fresh Non-donor
    • Frozen Non-donor
    • Egg & Embryo Banking
    • Fresh Donor
    • Frozen Donor
  • By Procedure
    • IVF with ICSI
    • IUI
    • IVF without ICSI
    • Surrogacy
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • India
      • China
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38657

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Fertility Services Market, By Services

7.1.  Fertility Services Market, by Services, 2021-2030

7.1.1.    Fertility Clinics

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Hospitals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Surgical Centers

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Clinical Research Institutes

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Fertility Services Market, By Services

8.1.  Fertility Services Market, by Services, 2021-2030

8.1.1.    Fresh Non-donor

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Frozen Non-donor

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Egg & Embryo Banking

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Fresh Donor

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Frozen Donor

8.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Fertility Services Market, By Procedure

9.1.  Fertility Services Market, by Procedure, 2021-2030

9.1.1.    IVF with ICSI

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    IUI

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    IVF without ICSI

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Surrogacy

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Fertility Services Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Services (2017-2030)

10.1.2.  Market Revenue and Forecast, by Services (2017-2030)

10.1.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Services (2017-2030)

10.2.2.  Market Revenue and Forecast, by Services (2017-2030)

10.2.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Services (2017-2030)

10.3.2.  Market Revenue and Forecast, by Services (2017-2030)

10.3.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Services (2017-2030)

10.4.2.  Market Revenue and Forecast, by Services (2017-2030)

10.4.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Services (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Services (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Services (2017-2030)

10.5.2.  Market Revenue and Forecast, by Services (2017-2030)

10.5.3.  Market Revenue and Forecast, by Procedure (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Services (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Services (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Procedure (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Services (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Services (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Procedure (2017-2030)

Chapter 11.  Company Profiles

11.1.              APOLLO HOSPITALS ENTERPRISE LTD.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              CARE FERTILITY GROUP LTD.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              CAROLINAS FERTILITY INSTITUTE

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              CITY FERTILITY

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              FERTILITY ASSOCIATES LIMITED

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              GENEA LIMITED

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              MONASH IVF GROUP LIMITED

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              PROGYNY INC.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           VIRTUS HEALTH

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38657

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button